These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16617013)

  • 1. Molecular regulation of an invasion-related molecule--options for tumour staging and clinical strategies.
    Allgayer H
    Eur J Cancer; 2006 May; 42(7):811-9. PubMed ID: 16617013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
    Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H
    Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers.
    Schewe DM; Biller T; Maurer G; Asangani IA; Leupold JH; Lengyel ER; Post S; Allgayer H
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8538-48. PubMed ID: 16361535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the urokinase receptor (u-PAR)--a central molecule of invasion and metastasis.
    Fuchs T; Allgayer H
    Biol Chem; 2003 May; 384(5):755-61. PubMed ID: 12817472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.
    Maurer GD; Leupold JH; Schewe DM; Biller T; Kates RE; Hornung HM; Lau-Werner U; Post S; Allgayer H
    Clin Cancer Res; 2007 Feb; 13(4):1123-32. PubMed ID: 17317820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers.
    Schewe DM; Leupold JH; Boyd DD; Lengyel ER; Wang H; Gruetzner KU; Schildberg FW; Jauch KW; Allgayer H
    Clin Cancer Res; 2003 Jun; 9(6):2267-76. PubMed ID: 12796395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational research on u-PAR.
    Allgayer H
    Eur J Cancer; 2010 May; 46(7):1241-51. PubMed ID: 20362429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and clinical significance of urokinase-receptor (u-PAR), an invasion-related molecule.
    Allgayer H
    Z Gastroenterol; 2006 Jun; 44(6):503-11. PubMed ID: 16773517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis.
    Soreide K; Janssen EA; Körner H; Baak JP
    J Pathol; 2006 Jun; 209(2):147-56. PubMed ID: 16691544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular regulation of urokinase-receptor gene expression as one potential concept for molecular staging and therapy.
    Allgayer H
    Recent Results Cancer Res; 2003; 162():15-30. PubMed ID: 12790318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of hepatic metastasis in colorectal cancer.
    Rudmik LR; Magliocco AM
    J Surg Oncol; 2005 Dec; 92(4):347-59. PubMed ID: 16299807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression.
    Wang H; Yan C; Asangani I; Allgayer H; Boyd DD
    Oncogene; 2007 Mar; 26(14):2058-70. PubMed ID: 17001307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting urokinase-type plasminogen activator and its receptor for cancer therapy.
    Nozaki S; Endo Y; Nakahara H; Yoshizawa K; Ohara T; Yamamoto E
    Anticancer Drugs; 2006 Nov; 17(10):1109-17. PubMed ID: 17075310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer invasion and metastasis: changing views.
    Duffy MJ; McGowan PM; Gallagher WM
    J Pathol; 2008 Feb; 214(3):283-93. PubMed ID: 18095256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urokinase plasminogen activator receptor as a gene therapy target for cancer.
    Pillay V; Dass CR; Choong PF
    Trends Biotechnol; 2007 Jan; 25(1):33-9. PubMed ID: 17084931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanisms of cancer metastasis--ets-related nuclear transcription factor play an important role in cancer metastasis].
    Kaya M; Yoshida K; Fujinaga K
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1225-34. PubMed ID: 8831733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
    Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/dormancy, clinical outcome and minimal residual disease.
    Laufs S; Schumacher J; Allgayer H
    Cell Cycle; 2006 Aug; 5(16):1760-71. PubMed ID: 16931909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.
    Serratì S; Margheri F; Fibbi G; Di Cara G; Minafra L; Pucci-Minafra I; Liotta F; Annunziato F; Pucci M; Del Rosso M
    J Pathol; 2008 Apr; 214(5):545-54. PubMed ID: 18189329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.